Associated Papers
ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation.
Zeng Q et al.
Elife, 2025
Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity.
Park YJ et al.
Cellular Signalling, 2020
Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity.
Kuniyoshi K et al.
Proceedings of the National Academy of Sciences of the United States of America, 2014
Select a paper to view details